M agnetic resonance imaging (MRI) is a highly effective modality for the detection and characterization of liver lesions. 1 Artifacts are commonly encountered on MRI and can lead to image degradation. While many artifacts lead to nondiagnostic or suboptimal images that are readily recognizable, some artifacts can result in imaging pitfalls that may challenge interpretation. In this article, we illustrate a spectrum of common technical pitfalls encountered in liver MRI that may lead to misdiagnosis or interpretation errors. We focus on technical and diagnostic challenges encountered when interpreting dynamic multiphasic T 1 -weighted (T 1 -w) imaging, hepatobiliary phase imaging, and diffusionweighted imaging of the liver. Recognizing and addressing these pitfalls requires some understanding of the MRI acquisition techniques. For each pitfall we use a case to illustrate how to recognize the pitfall. We then explain the cause of the pitfall and describe methods to avoid them, providing practical solutions for ameliorating or eliminating the cause of the pitfall.
Pitfalls of Pre-and Postcontrast T 1 -Weighted Sequences
Suboptimal Arterial Phase Timing When evaluating the liver on contrast-enhanced MR, one of the first steps should be to assess the adequacy of the postcontrast phases. A main consideration for image quality of dynamic postcontrast imaging is the timing of the acquisitions relative to the contrast administration, and, most important, the timing of the arterial phase. The arterial phase may be divided into early and late components. The early arterial phase is like an angiographic phase where the aorta and visceral branches enhance brightly; there is no venous enhancement (systemic or portal) or liver parenchymal enhancement. An early arterial phase may be acquired when vascular anatomy is a primary question, such as a living donor protocol. However, the probability of detecting arterially enhancing lesions is optimal when imaging is performed in the late arterial phase. The late arterial phase is defined by arteries enhancing brightly, the portal vein mildly enhances, and there is no antegrade enhancement of the hepatic veins.
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Whether or not multiphase arterial imaging is performed, it is critical to have at least one optimum late arterial phase acquisition when the clinical question is evaluation of a liver lesion. If the arterial phase is too early or too late, hypervascular liver lesions may be missed or mischaracterized (Fig. 1) . Timing of the late arterial phase may vary with cardiac output, vascular disease, and contrast infusion rate, among other factors. Given the importance of appropriate timing, different techniques have been employed to acquire an optimal late arterial phase. The simplest technique is a fixed or empiric delay, ranging from 20-30 seconds after the start of the injection. 3, [9] [10] [11] However, this method can often lead to suboptimal outcomes because it does not account for variability in cardiac output, venous capacity, injection rate or volume, or other variables. 3, 8 Methods more tailored to individual patient factors are recommended over a fixed or empiric delay. One such individualized approach is the test bolus technique. In this method, a small dose of gadolinium chelate contrast (typically 1-2 ml) is injected at the desired rate followed by a saline flush to determine the time to peak aortic enhancement (TTP). This is achieved by applying a single transverse high temporal resolution T 1 -w spoiled gradient-recalled-echo (SPGR) sequence through the aorta at approximately the level of the celiac axis following the test bolus injection. 2, 10, 12 Spatial saturation preparatory pulses are applied above the slice location to eliminate inflow time-of-flight flow-related enhancement, which can mimic contrast enhancement. TTP is qualitatively determined by the technologist or radiologist, and it is then used to calculate the optimal delay for the arterial phase using the following equation.
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Scan Delay = TTP + IT =2 + T ðtumor delayÞ -TTC In this equation, TTP is the time to peak aortic enhancement determined by the test bolus. IT is the injection duration, which is equal to the volume of contrast divided by the rate of contrast injection. T(tumor delay) is the delay period to peak tumor enhancement after peak aortic enhancement with recommended values in the range from 4-8 seconds. 12, 13 TTC is the time to the central k-space encoding and is specific to the type of acquisition. The center of kspace may be sampled at the midpoint of acquisition time, in the first few seconds of the scan, 3, 14 or in a more complex fashion (eg, radial) to enrich the center of k-space. Familiarity with the specific k-space acquisition method for each platform is required for optimum timing. There are a number of variants of the above equation described in the literature. 2, 10, 12, 13 Bolus tracking techniques have become the most commonly recommended timing method and works well in the setting of small volume contrast dosing and hepatobiliary contrast agents when using a test bolus is not desirable. 3 Bolus tracking is performed by applying a tracking sequence (typically a coronal or sagittal 2D gradient echo [GRE] ) to rapidly sample the aorta at the level of the descending thoracic or proximal abdominal aorta. Image acquisition can be initiated automatically using a tracker based on a specified signal threshold (eg, 20% above baseline) and a predetermined delay is programmed into the scanner following detection of aortic enhancement to allow for breath-holding and for the bolus to reach the area of interest. 2 The predetermined delay accounts for the estimated time to peak tumor enhancement (T(tumor delay)) and the TTC of k-space. During this delay, the breath-hold instructions are automatically given to the patient and, therefore, at least 5 seconds are needed to provide the instructions. This may require moving the tracker away, above the level of the celiac artery. A maximum monitor period, ranging from 6-12 seconds, can be set as a failsafe mechanism, in the instance that the "tracker" does not detect contrast arrival. 3, 8, [15] [16] [17] [18] Not all scanners are equipped with automated bolus detection, especially older systems. In the absence of the option, a large field-of-view sequence including the chest can be reconstructed and displayed in real time, so that the MR technologist can use visual cues, such as right atrial opacification, for providing breath-hold instructions and initiating image acquisition. While selection of a specific timing technique is determined by available technology and institutional preference, both the test bolus and bolus tracking techniques yield more consistent late arterial phase timing compared with the fixed timing technique. 10, 12, 16 With recent technological advances related to parallel imaging, compressed sensing, and view sharing, [19] [20] [21] [22] [23] [24] multiarterial phase (a.k.a., time-resolved) imaging has been investigated as an alternative option to traditional timing methods. 4, 20, [25] [26] [27] [28] Two or more arterial phases are acquired within a single breath-hold, thereby increasing the probability of capturing the optimal late arterial phase. Multiarterial phase imaging can be used with bolus tracking or fixed delay, and has been shown to improve the likelihood of acquiring a late arterial phase, 19, 21, 22 improving the detection and characterization of hypervascular lesions such as hepatocellular carcinoma (HCC). 23, 25, 26, 28 The different techniques used to acquire an optimal late arterial phase are summarized in Table 1 .
Respiratory Motion-Related Pitfalls
Conventional postcontrast 3D GRE sequences are sensitive to ghost artifacts from motion, which are transmitted throughout the entire imaging volume. Radiologists are generally well versed in the tradeoff between the requirement of a short breath-hold (limiting the entire acquisition time) to minimize motion, versus spatial resolution and coverage. Respiratory motion leading to a suboptimal or nondiagnostic examination is usually easy to recognize, so it is less likely to pose a potential interpretation pitfall. If the respiratory motion is subtle or preferentially affecting a portion of the liver, however, it can lead to missed lesions or falsely characterized enhancement patterns (Fig. 2) . Three general strategies have been used to minimize the effect of respiratory motion, particularly in patients who have difficulty with breath-holding. The first strategy is faster acquisition. Techniques such as parallel imaging, view sharing, and pseudorandom undersampling (compressed sensing), alone or in combination, enable the acquisition of 3D GRE sequences in less than 10 seconds. This allows maintenance of spatial resolution and coverage in a shorter breath-hold, although the signal-to-noise ratio (SNR) may be reduced. 29, 30 Similarly, acquiring multiple arterial phases during a standard breath-hold using fast T 1 sequences can improve the chances of obtaining at least one adequate arterial phase. 19 Caution, however, is advised when using view-sharing techniques without compensatory motion sorting, due to the possible propagation of the respiratory motion to all the acquisitions that share the same k-space data. 21 The second strategy is the use of non-Cartesian radial or spiral trajectories of k-space sampling. Radial techniques, due to their oversampling of the center of k-space, are inherently less sensitive to motion artifact. [31] [32] [33] [34] However, the length of radial 3D GRE acquisitions, on the order of 80-120 seconds, is too long for useful dynamic phase imaging of the liver. [31] [32] [33] [34] Free-breathing delayed postcontrast radial T 1 3D GRE has been shown to be of adequate quality in patients unable to comply with breath-holding [31] [32] [33] [34] [35] ; however, conventional breath-hold T 1 3D GRE remains superior in quality when not degraded by respiratory motion. 31, 32 Further research using novel reconstruction techniques related to view sharing and sparse sampling along with motion sorting applied to radial techniques may allow for free breathing, motion insensitive, continuous dynamic imaging in the future.
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The third strategy to address respiratory motion is the use of respiratory triggering or navigator-gated techniques. Their required acquisition times are on the order of 80-100 seconds; too long for dynamic multiphase liver imaging, but these techniques have been used to acquire high-quality delayed postcontrast imaging, particularly during the hepatobiliary phase. 43, 44 The strategies described to address respiratory motion are summarized in Table 2 .
"Washout": The Effect of Altered Background Liver Parenchyma A washout appearance is defined as a visually assessed temporal reduction in enhancement of an observation relative to composite liver tissue from an earlier to a later phase, resulting in hypoenhancement on the portal venous or delayed phases. 45 In general, washout is reported to have good interreader reliability 46 ; however, alterations of the background liver signal intensity can impact the detection of "washout" in a liver observation. The liver parenchyma can have abnormally low signal on a fat-suppressed T 1 -w GRE sequence due to iron deposition or severe steatosis. When the background liver is abnormally hypointense, observations may remain hyperintense or isointense to liver on all phases despite the washout kinetics of the observation (Fig. 3) . Alternatively, a severely fibrotic liver may present with increased background signal intensity on late postcontrast images, making areas of spared liver or regenerative nodules appear hypointense. Conversely, washout can be mimicked by increased hepatic signal due to hepatic parenchymal uptake of hepatobiliary agents (pseudo-washout, discussed in detail in the section on hepatobiliary phase [HBP] imaging, below). It is important to review multi-echo time (TE) sequences (eg, chemical shift or iron quantification sequences) and assess background liver signal intensity and morphology, as it may help narrow the differential diagnosis of focal abnormalities and avoid misinterpretation.
Subtraction Image Pitfalls
Subtraction is a postprocessing technique where the unenhanced T 1 -w dataset is digitally subtracted from the dataset performed post-intravenous contrast. In the settings of subtle hyperenhancement, severe steatosis, or intrinsic T 1 hyperintensity, the enhancement pattern of a mass in the liver may be challenging. In these patients, subtraction images can be useful, but caution in applying subtraction imaging is advised for several reasons.
First, misregistration, a result of slight positional differences between pre-and postcontrast structures, can lead to artifact and erroneous interpretation (Fig. 4) . Misregistration can mimic enhancement where there is none and vice versa. Recognition of misregistration is aided by noting marginal bright and dark bands around structures that indicate the offset between locations. Misregistration may not affect all structures, and careful comparison of the original source images, or images acquired in a different plane (coronal versus axial), may aid in interpretation.
Second, subtraction should only be performed between sequences with identical parameters. If there has been a change in parameters, subtraction of these sequences would not correctly represent tissue enhancement. Some scanners may apply automatic gains and changes to the sequence parameters between different postcontrast acquisitions, particularly if a different contrast is acquired in between, unless they are explicitly set to avoid that. This will render subtraction images unreliable, and even a comparison of the ROIs or a time curve would not be reliable in this case. This pitfall can be avoided by ensuring all postcontrast acquisition are set to the same parameters as well as knowledge of the scanner setting that may automatically alter the acquisition. Otherwise, subtraction imaging, comparison of ROIs, and time curves cannot be used. Third, subtraction is often manually performed by the technologist or automatically by the scanner and errors can occur subtracting the wrong temporal combination of datasets such as subtraction of the postcontrast dataset from the precontrast or subtraction of an early postcontrast from a later postcontrast and lead to erroneous, misleading datasets.
In assessing suspected or treated HCC using the Liver Imaging Reporting and Data System (LI-RADS), subtraction imaging can be a useful tool for confirming arterial phase 
Strategy Comments
Faster imaging -Reduces the length of breath-hold by acquiring 3D GRE in 10 seconds or less using techniques such as parallel imaging, view sharing and pseudorandom under-sampling (compressed sensing) alone or in combination.
Multiple arterial phases -Relies on the faster imaging strategies described above.
-Improve the chances of obtaining at least one adequate late arterial phase free of respiratory motion. -Caution is advised when using view-sharing techniques without compensatory motion sorting.
Radial/spiral k-space sampling techniques -These techniques are inherently less sensitive to motion artifact.
-They allow for acquiring delayed free-breathing 3D GRE sequence.
-The length of acquisition of currently commercially available techniques precludes use in dynamic multiphase liver imaging. Emerging techniques may challenge this limitation in the near future.
Respiratory triggering or navigator-gated techniques -Can be useful for delayed image, particularly the hepatobiliary phase.
-Length of acquisition precludes use in dynamic multiphase liver imaging. hyperenhancement 45 ; however, the incremental benefit of subtraction imaging in assessing washout is uncertain. 47 Additionally, most existing literature validating the diagnostic value of arterial phase hyperenhancement (APHE) and washout for diagnosing HCC has relied primarily on visual analysis of source images rather than quantitative or subtraction techniques. LI-RADS does not currently require subtraction images for assessing APHE and washout for diagnostic purposes. On the other hand, subtraction imaging is particularly useful in assessing response to locoregional therapy, where it was found to have excellent concordance with pathological assessment of tumor necrosis. 48 
Pitfalls of Gadoxetate Disodium Use
Arterial Phase Degradation With Gadoxetate Disodium Acquiring high-quality late arterial phase images when using gadoxetate disodium contrast agent may be challenging for multiple reasons. 18 The approved dose of gadoxetate disodium of 0.025 mmol/kg is a quarter of the gadolinium dose of approved extracellular agents. This low dose is partly offset by the high relaxivity of gadoxetate disodium, which is approximately double that of many other gadolinium chelates. However, the administered volume of gadoxetate disodium is half that of most other gadolinium chelates, potentially resulting in a narrower window to capture the late arterial phase. Mistimed late arterial phase can result in diminished sensitivity for detection of arterially enhancing lesions, as discussed previously. As a potential solution, some centers dilute the contrast bolus with saline or use a slower injection rate (1-1.5 cc/sec rather than 2 cc/sec) to help mitigate this issue. [49] [50] [51] While it might seem logical to increase the dose of contrast, there has been a reported association between higher dose and increased rate of transient arterial phase severe motion artifact (discussed below). Transient severe motion due to acute transient dyspnea was first described by Davenport et al in 2013, who noted significantly more frequent degradation of arterial phase images due to motion (Fig. 5) and patients reported more symptoms of shortness of breath when injected with gadoxetate disodium as compared with an extracellular contrast agent. 52 While considered controversial initially, this phenomenon has been reproduced in subsequent studies. 53 The reported frequency of transient severe motion resulting in degradation of the late arterial phase ranges from 10-19.4%. 20, 29, 52 Transient severe motion artifact also appears to be dose-related, with increased incidence with the use of 20 ml of gadoxetate disodium compared with 10 ml. 54 Methods to mitigate transient severe motion use the same strategies described in the prior sections, primarily focusing on speed of acquisition 29, 55 and/or the acquisition of multiple arterial phases. 20, 21 However, as previously mentioned, view-sharing techniques without compensatory motion sorting can result in propagation of the motion to all the acquisitions that share the same k-space data. 21 The techniques described to minimize arterial phase degradations when using gadoxetate disodium are summarized in Table 3 . 
Strategy Comments
Slower contrast injection -Reducing the injection rate from 2 ml/s to 1 m/s, stretches the bolus and is more optimal for arterial phase imaging. 49 Dilution of contrast -50% dilution with saline injected at standard rate. This method has been found to reduce arterial phase degradation in few recent articles. 50, 51 Faster imaging -Reduces the length of breath-hold by acquiring 3D GRE in 10 seconds or less using techniques such as parallel imaging, view sharing and pseudorandom under-sampling (compressed sensing) alone or in combination.
-Improve the chances of obtaining at least one adequate late arterial phase free of respiratory motion. -Caution is advised when using view-sharing techniques without compensatory motion sorting. 
Pseudo-Washout Appearance
Pseudo-washout is the term used to describe the hypointense appearance of lesions that do not have true washout on transitional and HBP imaging. 55 This results from the increased enhancement of the background liver due to hepatocyte uptake of contrast, contrasted with the lack of uptake within the lesion itself (Fig. 6 ). When using extracellular contrast agents, washout appearance can be assessed on the portal venous phase, and/or the equilibrium phase. Equilibrium phase, 3-5 minutes postcontrast, refers to the phase of contrast when the concentration of the extracellular contrast agent is similar in the microvasculature and the extracellular interstitial space. Hepatocyte uptake of gadoxetate disodium begins immediately, and may already be substantial by the portal venous phase (90 sec). Hence, the standard equilibrium phase is not achieved, and instead there is a transitional phase in which there is progressive enhancement of the background liver parenchyma due to increasing uptake of gadoxetate disodium by the hepatocytes. The transitional phase is defined as the time frame between the portal venous phase (90 sec and the HBP (10-20 min). During this time, there is rapid removal of contrast from the vascular and interstitial spaces, hepatocellular uptake, and excretion of contrast into the biliary system, and renal excretion as well. The distribution of contrast among four different compartments (vascular, interstitial, hepatocyte, and biliary) alters the relative enhancement of lesions compared with the background liver, as compared with the appearance with extracellular contrast agents.
The classic example of this alteration is pseudo-washout, which was first described in hemangiomas by Doo et al in 2009 56 and characterized by a hemangioma becoming hypointense relative to the background liver during the transitional phase. The pseudo-washout sign is reportedly more common in high-flow rapidly enhancing hemangiomas, 57, 58 which can pose a diagnostic dilemma, challenging definitive characterization of these lesions as benign. 58 Pseudo-washout has also been described in mass-forming intrahepatic cholangiocarcinomas. 59 In recognition of this potential limitation, LI-RADS specifies that washout appearance on postgadoxetate images only be assessed on portal venous phase images and defines transitional phase hypointensity as an ancillary feature favoring malignancy, not specific for HCC. 45, 47 HBP Hypointensity: False Positives One of the main advantages of gadoxetate disodiumenhanced MRI is its increased sensitivity to hepatic lesions on HBP. However, focal hepatic parenchymal functional defects can simulate a lesion. Figure 7 illustrates one such example of focal parenchymal steatosis that simulates a lesion on HBP. In this case, focal deposition of fat resulted in a low signal of the lesion on precontrast fat-suppressed T 1 images. After contrast administration, the area enhanced similar to the adjacent liver parenchyma, and therefore remained relative hypointense throughout all phases. Examination of all pulse sequences for additional signal abnormalities or mass effect is critical to differentiate between pseudolesions due to focal fibrosis, perfusion variations, or other functional deficits. In the case of focal steatosis, comparison of opposed-phase and in-phase images should prevent misdiagnoses. 
Suboptimal HBP Imaging: Causes and Effect
Suboptimal HBP is common in patients with impaired hepatobiliary function. A suboptimal HBP is characterized by liver parenchyma that is iso-or hypointense to the hepatic blood vessels, and by lack of excretion of contrast into the biliary tree and persistent contrast within the spleen. [60] [61] [62] Excretion of gadoxetate disodium may be decreased due to a combination of diminished functional liver, cholestasis, or downregulation of or competition for transporters. 63, 64 The sensitivity for liver lesion detection and subsequent characterization can be reduced when the HBP is suboptimal 65 (Fig. 8) . A liver lesion may appear isointense to the liver background on a suboptimal HBP, mimicking uptake and retention of the hepatobiliary agent. To be attuned to the possibility of this pitfall, radiologists should consult the clinical history for advanced cirrhosis (Child-Pugh B and C cirrhosis), which is associated with reduced parenchymal enhancement. 66, 67 Elevated bilirubin also correlates with decreased parenchymal enhancement. 66 Lengthening the delay for the HBP beyond 20 minutes has been suggested to ameliorate this pitfall; however, with no supporting evidence at this time. 67 Most important is to evaluate the quality of hepatic parenchymal hepatobiliary enhancement before relying on this phase of postcontrast imaging.
Pitfalls in Diffusion-Weighted Imaging (DWI) / Apparent Diffusion Coefficient (ADC) Map Interpretation
Variable Appearance of Cysts and Hemangiomas on DWI Diffusion refers to the random thermally driven motion of water molecules. Interaction of water molecules with surrounding cellular structures and other molecules affects their diffusivity, reducing free and random movement. Diffusion imaging is a T 2 -weighted (T 2 -w) echo planar sequence with gradients on either side of a 180 pulse applied to dephase and then rephase protons. Stationary molecules will be affected equally by both gradients, and thus display greater signal compared with mobile molecules, which will experience different gradient strengths prior to and following the 180 pulse. The sensitivity to diffusion is defined by the b value. Images with b = 0 are essentially fat-suppressed T 2 -w images. Images with a low b value, such as 20 or 50, are often used to dephase signal of flowing blood with little effect on soft tissues, producing dark-blood T 2 -w echo planar images. Images with higher b value images (eg, 400 or higher) show reduced signal caused by water random motion (diffusion), and therefore depict diffusion restriction as bright signal relative to other tissues. DWIs are acquired using at least two b values, to clearly demonstrate the effects of diffusion, and to produce quantitative data in the form of the ADC. ADC is the slope of logarithmic change in signal as a function of b-value. Hence, tissues that restrict diffusion will have low ADC values.
In normal extracellular spaces, water molecular random motion is relatively free. However, within cells or in the presence of large molecules, motion can be hindered or "restricted." Tissues with high cellularity, such as malignancies, restrict the free motion of water molecules and hence demonstrates "restricted diffusion." Some extracellular environments may also restrict diffusion when interstitial pressure is high (eg, inflammation) or if there is highly structured tissue (eg, thrombus). Water molecules within hepatic cysts are freely mobile and hence do not have restricted diffusion.
DWI is useful for detection and characterization of liver lesions. It frequently shows metastases that may be difficult to see on T 2 -w or contrast-enhanced images alone. 68 DWI is helpful in distinguishing liver cysts and most hemangiomas from malignant lesions. 68 Some hemangiomas with slow flow may have less water motion than adjacent hepatic parenchyma, resulting in similar or even lower ADC values, and thus be challenging to characterize on DWI. 69 As mentioned above, DWI is a T 2 -w echo planar sequence, so signal intensity on DWI depends on both water molecule diffusivity and the tissue T 2 relaxation time. Thus, long T 2 can result in high signal on diffusion images even when there is no restricted diffusion, a phenomenon described as "T 2 shine-through." T 2 shine-through can be recognized by comparing images with low and high b values, or by noting high ADC value on an ADC map. Cysts may be bright or dark on high b-value images, but in either case, the corresponding ADC value will be high (Fig. 9) . The ADC for a specific lesion can be obtained by measuring an ROI on the ADC map. ADC values can serve as a useful adjunct for differentiation of benign from malignant liver lesions, although there is sufficient overlap in numerical values that as a stand-alone metric, the clinical application of ADC quantitative imaging for diagnosis remains questionable. 68 T 2 shine-through can be reduced by using higher b values, such as 800 or 1000 rather than 400 or 500.
Variable Appearance of Malignancies on DWI Solid metastases are readily detectable on DWI, 68 but mucinous or cystic (necrotic) metastasis may largely contain liquid contents as opposed to solid tumor, and therefore may not show restricted diffusion (Fig. 10) . Their appearance on DWI may therefore resemble that of liver cysts, and may even have a high ADC value. Recognizing these possibilities and carefully considering the patient history is important to avoid dismissing cystic or mucinous metastases as benign cysts.
Hemorrhage Showing Restricted Diffusion
Restricted diffusion, while a surrogate marker of high cellularity, is not specific and can occur with hemorrhage or inflammation, both of which can feature reduced mobility of water molecules (Fig. 11) . 70, 71 Recognizing the possibility of a hemorrhagic cyst, thrombus, or coagulative necrosis, and comparing the DWI to the T 1 and T 2 images is important when characterizing liver lesions with restricted diffusion. Establishing a benign diagnosis requires confirmation by careful comparison of pre-and postcontrast T 1 -w images. ADC values are a potential biomarker of response assessment after locoregional liver therapy. [72] [73] [74] However, in clinical practice the use of DWI is primarily based on qualitative assessment of the high b value DWI sequences, and comparing these to low b value images and the ADC map. Posttreatment intralesional hemorrhage often has restricted diffusion, and therefore can confound the appearance of a treated tumor on DWI and on ADC maps. In clinical practice, assessment of response remains dependent on the morphology and size change and enhancement characteristics of the treated lesion. For hypervascular lesions, such as HCC, LI-RADS, and mRE-CIST criteria rely primarily on residual arterial phase hyperenhancement rather than overall lesion size. 75 
Misregistration Artifact
Performing DWI in the abdomen is challenging due to the large imaging volume, heterogeneous susceptibility due to multiple air-tissue interfaces, and the various sources of motion. 76 As previously mentioned, DWI is performed with fat-suppressed single-shot echo-planar imaging (EPI). 68, 77 Since EPI is a rapid technique, imaging of the entire liver can be performed during one or two breath-holds. 76 However, breath-hold EPI suffers from poor SNR. 78 More commonly, DWI is acquired using respiratory triggering, or a freebreathing technique with averaging of multiple acquisitions. Free breathing with averaging of multiple acquisitions is operator-independent and has high SNR because of signal averaging. Additionally, thinner slices and more b-values can be obtained, which may not be feasible during a single breath-hold. The cyclical nature of breathing is a coherent motion, which only has a small effect on the signal and on the calculated ADC of the background liver. 76, 77, 79 However, the respiratory motion can affect tissue interfaces and therefore may have a substantial effect on assessing small liver lesions. 76, 79, 80 Bulk patient motion may further affect the ADC map. Motion artifact in DWI can thus limit the reproducibility of DWI measurements in the abdomen. 81 The effect of motion and volume averaging may vary among the different b-value acquisitions, leading to spatial misalignment in the calculated ADC map, 79, 82 sometimes resulting in a "yin-yang" appearance (Fig. 12) . Various strategies can be used to minimize misregistration artifact and its effects on ADC calculations. Acquiring more than two b-values and using them to calculate the ADC map will reduce the effect of motion in one of the b-values on the final ADC map. Respiratory motion artifacts can also be reduced by respiratory triggering techniques, which synchronize image acquisition with the patient's breathing cycle by means of navigator echoes that track the diaphragm, or a bellows/belt that senses the chest expansion. Respiratory triggering may improve the DWI data quality at the cost of increasing imaging time, and potential for complex impact on quantitative ADC values, potentially reducing reproducibility. 68, 80, 83, 84 Another technical pitfall related to DWI is poor image quality because of insufficiently optimized parameters. Low SNR and image distortion are exacerbated when TE is longer than necessary. One common error is to use an image matrix comparable to that used for other pulse sequences, which requires a long acquisition window for the echo planar data. This can be shortened considerably by lowering the FIGURE 12: DWI misregistration artifact mischaracterizes a hemangioma on the ADC map: Single-shot fast spin-echo image (a) demonstrates a bright hemangioma (arrow). On the DWI b-800 s/mm 2 image (b) the hemangioma has high signal (arrow) due to T 2 shine-through. On the ADC map (c) the hemangioma (arrow) posteriorly has markedly low ADC (dark portion) and the anterior portion has markedly high ADC (bright portion), causing a "yin-yang" appearance. This occurred due to misregistration of the b-value image sets due respiratory motion during the acquisition and does not indicate restricted diffusion. The misregistration can be recognized around the edges of the liver and spleen (arrowheads).
acquisition matrix, such as to 128 by 128. The use of high bandwidth and the simplest possible gradient waveform shapes can also help shorten the acquisition window and the TE. Averaging multiple signals will also improve SNR, so that b-values of 800 or higher can be used without leading to low image quality. A typical number of signal averages (NSA) in clinical practice is 3-5; however, a higher NSA, as many as 10-12, can be performed when acquiring higher b-values.
Pulsation Artifact in the Left Lobe
Signal loss in the left lobe of the liver is generally attributed to cardiac motion. 68, 77, [84] [85] [86] It is most pronounced at higher b-values 77 and leads to artificially elevated ADC 86, 87 and reduced sensitivity to lesions 85 in the left lobe (Fig. 13 ). This may result in failure to detect a lesion or ADC miscalculations. One way to minimize this artifact is pulse triggering or cardiac triggering to the diastolic heart phase at image acquisition. 77, 87 However, this comes at a significant time cost in prolonging the acquisition, particularly if combined with respiratory triggering techniques, and it is therefore not commonly used in clinical practice. 84 Pitfall of Size Measurement on DWI/ADC Lesion size measurements are an important biomarker to assess response to treatment. Careful selection of the most appropriate series used for comparison is required. The same series/sequence should be used to compare pre-and posttreatment changes whenever possible. A common artifact encountered in DWI is geometric distortion, an inherent limitation of the EPI acquisition technique. 76, 88 Geometric distortion is exaggerated by higher static magnetic field strength and by the presence of air-tissue interfaces (Fig. 14) . For this reason, as well as the generally lower spatial resolution, it is prudent not to use diffusion-weighted images for measuring lesions whenever lesion margins are clearly depicted on other images. Emerging DWI techniques such as readout-segmented echo-planar DWI and selective excitation reduced FOV offer theoretical advantages to tackling geometric distortion.
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Effect of Changes in Background Liver on DWI/ADC Liver fibrosis, iron deposition, and steatosis can alter the background signal of the liver on DWI. Liver fibrosis and cirrhosis reduce DWI signal, [93] [94] [95] possibly due to increased connective tissue. 77, 94 Iron deposition in the background liver causes signal decay on the echo planar images used for DWI sequences, reducing SNR and, if severe, may render the DWI nondiagnostic 96, 97 or reduce the background liver ADC. Hepatic steatosis may reduce liver ADC, potentially FIGURE 14: Geometric distortion on DWI affects size measurement: ADC map (a) and single-shot fast spin-echo (b) images of a presumed sclerosing hemangioma in the hepatic dome. The ADC map demonstrates anatomic distortion of the hepatic dome. due to restricted diffusion of water molecules because of the enlarging lipid-filled hepatocytes. 96, 98, 99 However, one study suggested that ADC reduction is at least in part artifactual due to residual fat signal near the water peak. 100 Reduction of the background ADC from any cause will alter the ratio of the lesion-to-background ADC. Lesions with restricted diffusion may have similar or even have higher ADC than background if the background ADC is sufficiently reduced, and therefore these lesions may be difficult to differentiate from surrounding cirrhotic liver (Fig. 15) . 65, 77, 101 Recognition of background iron on other sequences such as T 2 -w TSE, low b value DWI, or other T 2 -weighted images, or by comparing gradient echo images with different TE (eg, in/out-of-phase), can confirm the presence of iron.
Conclusion
We have illustrated various technical pitfalls with some commonly used techniques in liver imaging. Avoiding these pitfalls starts with optimizing the sequence acquisition. During interpretation, it is important to consider all available information from multiple sequences and not solely rely on one sequence. Awareness of these pitfalls is essential to recognize them and avoid subsequent interpretation errors. Various technical advancements are evolving to address some of these pitfalls. 
